© 2019 by ATXA Therapeutics Limited.

Dublin, Ireland

Home  |  About Us  |  News  |  Contact Us

Follow us on:

  • LinkedIn Social Icon
  • Facebook Social Icon
  • Twitter Social Icon

Funding Opportunities for Breakthrough Innovation

May 2, 2019

ATXA Therapeutics Founder and CSO, Prof Therese Kinsella will represent the company at an event on the European Innovation Council Funding Opportunities for Breakthrough Innovation. This event is hosted by the European Commission Representation in Ireland and will take place on Friday 3rd May 2019.

 

The European Innovation Council (EIC) will offer €2bn for the financing of disruptive, market-creating innovation in its pilot phase between 2019-2020, in view of setting up a fully-fledged EIC under the next EU budget (2021-2027).

 

 

Share on Facebook
Share on Twitter
Please reload

Please reload

Archive
Search By Tags
Recent Posts

September 30, 2019

Please reload

Please reload